Mckesson Recalls Xanax Tablets Due to Missing Primary Packaging Labels
Mckesson Packaging Services is recalling 3,492 cartons of Xanax (Alprazolam) 0.5 mg tablets because the primary blister card labels are blank and lack product information.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The issue is a packaging and labeling defect (missing primary label) rather than a contamination or structural defect.
Plain-English summary
Mckesson Packaging Services is recalling 3,492 unit cartons of Xanax (Alprazolam) USP, CIV, 0.5 mg tablets. The product is identified by NDC 63739-669-10, Lot # 0111512, and an expiration date of 08/17. The recall was initiated because the primary packaging labels, specifically the blister cards, are blank and do not contain required product information such as the product name, strength, lot number, or expiry date.
The affected units were distributed to Colorado, Illinois, Louisiana, and Ohio. The tablets were manufactured by Sandoz Inc. in Princeton, NJ, and packaged by Mckesson Packaging Services.
Consumers who possess this specific lot of Xanax should stop using the product and contact their healthcare provider or pharmacist for guidance. Because the primary labels are missing, patients may be unable to verify the identity or strength of the medication, which poses a risk of medication errors.
The recalled product
- Product
- Xanax (Alprazolam) USP, CIV, 0.5 mg tablets , 10 x 10 blister cards per carton, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08805, NDC 63739-669-10
- Manufacturer
- Mckesson Packaging Services
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 0111512
- Exp. 08/17
Distribution
Related recalls
Same manufacturer · Mckesson Packaging Services
See all →- ModerateMcKesson Recalls Diltiazem CD Capsules Due to Dissolution Failures
FDA (Drugs) · 2018-05-02
- LowMcKesson Recalls Diltiazem HCl Extended-Release Capsules Due to Dissolution Failures
FDA (Drugs) · 2018-05-02
- ModerateMcKesson Recalls Diltiazem HCl Extended-Release Capsules Due to Dissolution Failures
FDA (Drugs) · 2018-05-02
- ModerateRanitidine Tablets Recalled for Failed Stability Specifications
FDA (Drugs) · 2018-03-14
- ModerateMcKesson Recalls Subpotent Megestrol Acetate Oral Suspension
FDA (Drugs) · 2018-02-14
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02